In another sign that the pandemic may have permanently altered the way employees work, GlaxoSmithKline said it is downsizing its office footprint.
This week, the company announced that it is leaving the North Carolina Research Triangle Park (RTP) digs it has occupied since 1983 for a new space in Durham. Although it is leaving the 561,652-square-foot RTP campus, GSK has said it will not be reducing its staff. About 1,300 employees who currently work at the RTP location have both remote and hybrid flexibility permanently — a post-pandemic shift for the company. The company expects half of its employees to work at its facilities in-person due to the flexibility.
The new Durham location is approximately 68,000 square feet and is located in the Crowe and Fowler buildings on the American Tobacco Campus. The move is expected to occur during the first half of 2022.
GSK is not the only pharma company downsizing. Pfizer also announced it’s selling its office and laboratory space in Collegeville, PA, saying that it’s looking for a more “modern and flexible” workspace for returning employees. Novartis also plans to develop a hybrid at-home/in-office work environment.
